ATE87473T1 - Arzneimittel zur inhibition von hautfalte. - Google Patents

Arzneimittel zur inhibition von hautfalte.

Info

Publication number
ATE87473T1
ATE87473T1 AT87903569T AT87903569T ATE87473T1 AT E87473 T1 ATE87473 T1 AT E87473T1 AT 87903569 T AT87903569 T AT 87903569T AT 87903569 T AT87903569 T AT 87903569T AT E87473 T1 ATE87473 T1 AT E87473T1
Authority
AT
Austria
Prior art keywords
hydroxy
halogen
different
same
medications
Prior art date
Application number
AT87903569T
Other languages
English (en)
Inventor
Richard Dexter Lippman
Original Assignee
Block Drug Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Block Drug Co filed Critical Block Drug Co
Application granted granted Critical
Publication of ATE87473T1 publication Critical patent/ATE87473T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Heat Treatment Of Steel (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87903569T 1986-05-05 1987-05-04 Arzneimittel zur inhibition von hautfalte. ATE87473T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/859,464 US4695590A (en) 1986-05-05 1986-05-05 Method for retarding aging
EP87903569A EP0265514B1 (de) 1986-05-05 1987-05-04 Arzneimittel zur Inhibition von Hautfalte
PCT/US1987/001039 WO1987006829A1 (en) 1986-05-05 1987-05-04 Method for inhibiting aging

Publications (1)

Publication Number Publication Date
ATE87473T1 true ATE87473T1 (de) 1993-04-15

Family

ID=25330990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87903569T ATE87473T1 (de) 1986-05-05 1987-05-04 Arzneimittel zur inhibition von hautfalte.

Country Status (8)

Country Link
US (1) US4695590A (de)
EP (1) EP0265514B1 (de)
JP (1) JPH0714867B2 (de)
AT (1) ATE87473T1 (de)
AU (2) AU7484887A (de)
CA (1) CA1305669C (de)
DE (1) DE3785136T2 (de)
WO (1) WO1987006829A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008294A (en) * 1985-02-11 1991-04-16 Chemex Pharmaceuticals, Inc. Methods of treating tumors with compositions of catecholic butanes
US5276060A (en) * 1979-06-19 1994-01-04 Block/Chemex, G.P. Methods of treating tumors with compositions of catecholic butanes
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
EP0289506A4 (en) * 1986-11-19 1990-12-12 Chemex Pharmaceuticals, Inc. Lipoxygenase inhibitors
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5308874A (en) * 1992-06-26 1994-05-03 Vyrex Corporation Airborne protectants against oxidative tissue damage
US5409690A (en) * 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US20050020672A1 (en) * 1994-04-08 2005-01-27 The Procter & Gamble Company Methods of extending mammalian life span via iron chelating compounds that reduce free radical damage in mammals
US6048545A (en) * 1994-06-24 2000-04-11 Biozone Laboratories, Inc. Liposomal delivery by iontophoresis
US5627187A (en) * 1995-04-12 1997-05-06 Katz; Bruce E. 5-FU for treating actinic kerotoses
US5631245A (en) * 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
CA2270898A1 (en) 1996-11-06 1998-05-14 The Regents Of The University Of California Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
AU8759298A (en) * 1997-10-06 1999-04-27 Shaman Pharmaceuticals, Inc. Use of nordihydroguaiaretic acid to lower serum triglycerides, blood pressure and to treat syndrome
EP1051165A2 (de) 1998-01-26 2000-11-15 Mitokor Schutzmittel für mitochondrien zur behandlung von mitochondrialererkrankungen
EP1222920A3 (de) * 1998-01-26 2003-03-12 Mitokor Schutzmittel für Mitochondrien zur Behandlung von mitochondrialen Erkrankungen
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US20060063738A1 (en) * 2000-02-28 2006-03-23 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US20030082647A1 (en) * 2000-12-12 2003-05-01 Reenan Robert A. Transporter protein
EP1399553A2 (de) 2000-12-12 2004-03-24 The University of Connecticut Für zelluläre transportproteine kodierende nukleinsäuren und methoden zur verwendung daraus
CN102300578A (zh) * 2008-12-01 2011-12-28 延寿有限责任公司 用于改变健康、安康和寿命的方法和组合物
US20110150856A1 (en) * 2009-12-21 2011-06-23 Sarah Bacus Compositions and methods for treatment of vitiligo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2644822A (en) * 1949-08-26 1953-07-07 Sulphite Products Corp 2, 3-bis-(oxybenzyl)-butane derivatives
FR3866M (fr) * 1964-07-08 1966-01-24 Rocal Médicament a base de dérivé du pyrocatéchol.
US3934034A (en) * 1972-08-21 1976-01-20 Sandoz, Inc. Hydroxy substituted diphenylalkyls for treatment of lipidemia
US4530844A (en) * 1984-07-26 1985-07-23 Warner-Lambert Company Synergistic non-steroidal anti-inflammatory compounds and compositions thereof

Also Published As

Publication number Publication date
DE3785136T2 (de) 1993-08-05
US4695590A (en) 1987-09-22
JPH01500120A (ja) 1989-01-19
AU7484887A (en) 1987-12-01
AU6930591A (en) 1991-03-28
EP0265514A4 (de) 1990-01-11
AU645771B2 (en) 1994-01-27
EP0265514A1 (de) 1988-05-04
WO1987006829A1 (en) 1987-11-19
JPH0714867B2 (ja) 1995-02-22
DE3785136D1 (de) 1993-05-06
CA1305669C (en) 1992-07-28
EP0265514B1 (de) 1993-03-31

Similar Documents

Publication Publication Date Title
ATE87473T1 (de) Arzneimittel zur inhibition von hautfalte.
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
ATE202337T1 (de) Cyclopropylalkansäurederivate
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
NZ196700A (en) Anti-inflammatory compositions containing 5-benzoyl-1-methylpyrrole-2-acetic acid derivatives
AU552908B2 (en) 4 n-phenyl benzyl-aminomethyl-imidazole
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
IL63782A (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles,their preparation and pharmaceutical compositions containing them
EP0186023A3 (de) Gallensäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
IL95279A0 (en) Cycloalkylene azoles,processes for the preparation thereof and pharmaceutical compositions containing same
IE42763L (en) Tertiary amino alkylphenyl ether compounds, anesthetics
DE3668888D1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
IE780279L (en) Imidazole derivatives
HK47592A (en) Piperazine derivatives
GB1472502A (en) Sulphonylurea derivatives
ZA949595B (en) Glutaramide derivatives
SE7412163L (de)
ES2007784A6 (es) Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea>
GB1503626A (en) Substituted piperazine derivative its preparation and compositions containing it
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient
JPS5673024A (en) Antihyperlipemic agent
GB1457950A (en) Antibacterial compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee